It is plausible to suggest that antibiotic treatment permeabilises the bacterial membrane, enabling the entry of CFTR modulators, where they can exert a direct antimicrobial effect potentially reducing pathogenic burden within CF airways and reducing infection. The gene discussed is CFTR; the disease is cystic fibrosis.